You must enable your browser's JavaScript functions, in order to fully utilize the Certaindri.com website.

For more information on how we use JavaScript and Cookies to improve your user experience, please read here.

$60 for 60 Years Donors ** Naomi Prever ** Gladys B. Lipkin ** Rita Miller ** JoAnne Goldberg **  Ann Stern **  $60 for 60 Years Donors ** Rita Seiff  ** Diane Stewart ** Gloria Supran ** Hannah and Stan Scheff  ** Sherrie Bieber **  $60 for 60 Years Donors ** Trudy and Joel Balizer ** Joan Klein ** Rayna Becker ** Roselyn Kessler ** Helene Riffle ** $60 for 60 Years Donors ** The Board of Valencia Palms ** All The Members of Valencia Palms ** Melody Iden **  Hally Shaw ** Joyce Wallach ** Rita Feuerstadt **  $60 for 60 Years Donors ** Boca West Chapter ** Arlene Dworkis ** Woodfield Chapter  ** Alfred Chiuchiolo ** Doreen Berman ** Jeffrey Schachter ** Ronald and Barbara Schubert ** $60 for 60 Years Donors ** Fredda Gleichenhaus ** Helene Brill ** Helen and Sid Rose ** Phyllis and Marshall Goldberg **Helene and Walter Kaley ** Ponte Vecchio West Chapter **  $60 for 60 Years Donors ** Gloria and Ron Berkowitz ** Merle Mash ** Three Island Chapter ** Villa Borghese Chapter ** Shirley Ottchick ** Shelly Studley ** $60 for 60 Years Donors ** Sheila Olin ** Valencia Falls Chapter **  The Board of Valencia Lakes Cancer Research Chapter ** Jan and Jeff Greenhawt **  Althea and Sam Goldberg ** Marlene Waller ** Andrea Press **

Using Math to Fight Cancer

Cancer Research At Work

Published Thursday, September 15, 2011 7:00 am
by Dr. Joseph Rosenblatt

 A tumor can either lie dormant, or be nourished by a network of underlying vessels that expands as the tumor develops. 

 These vessels also provide a way for the cancerous cells to travel to other parts of the body, settle and grow – a process called metastasis.

 Based on this reality, researchers from the University of Miami and the University of Heidelberg in Germany have developed a mathematical model to understand and predict the progress of a specific tumor.  The study reveals a hidden connection between the tumor and the nutrient-supplying vessels. The method outlines paths of future tumor expansion and identifies specific points in the vessels that can be targeted to control the tumor’s growth.

 One interesting aspect of the model is that it's based on the distribution of feeding vessels in a tumor section. Since the vessels both feed and are fed by the tumor, it is possible to estimate the growth characteristics for a patient's tumor. This type of estimate can potentially be applied to a better design of treatment schedules for cancer patients, explains Joseph D. Rosenblatt, M.D., interim director of Sylvester Comprehensive Cancer Center and co-principal investigator of the study. "This method could be used to predict growth rates in the human setting and to model effects of agents that specifically target supporting processes that sustain the tumor," Rosenblatt says. “Our model may be useful in designing treatment intervals and dosage schedules based on more accurate assessment of growth dynamics and the interdependence of tumor growth and blood vessel formation.”

Neil Johnson, Ph.D., professor of physics, director of the Complexity Research Group at UM College of Arts and Sciences, was co-principal investigator of the study.

He explains that “Cancer is a disease of many scales. There are the individual cells, the cells that group together to form the tumor, the vasculature and finally metastasis. By including information about how the tumor grows in response to its nutrients, and how the growth of the tumor feeds back the nutrient supply itself, our model moves us one step closer to predicting the future evolution of a patient’s tumor.

It opens up a path toward personalized treatment and intervention.”

 By analyzing images of tumor sections for distribution of tumor cells and tumor vasculature, the researchers created a simple model that predicts the most likely course of the disease, says Sehyo Choe, post-doctoral research fellow at the Division of Theoretical Bioinformatics at the German Cancer Research Center in Germany and at the Institute for Pharmacy and Molecular Biotechnology University of Heidelberg; and co-principal investigator of the study.

 “Our model implements local differences of a tumor directly extracted from in vivo images, and the parameters are directly measurable for each cancer,” Choe says. “By doing so, we believe we are one step closer to eventually building a model that will be able to describe a likely corridor of progression of a cancer, based on real-time information of a specific patient from images and other patient-specific data.”

This study is an exciting step forward in the search to cure all types of cancer. It highlights why The Pap Corps is proud of our association with Sylvester and its partnerships with cancer research centers around the world.